• 1. An investigation on the second-order nonlinear optical response of cationic bipyridine or phenanthroline iridium(iii) complexes bearing cyclometallated 2-phenylpyridines with a triphenylamine substituent?
  David B. Cordes,Alexandra M. Z. Slawin,Stefania Righetto,Denis Jacquemin,Eli Zysman-Colman,Véronique Guerchais Dalton Trans., 2018,47, 8292-8300
• 2. An Aptamer Bio-barCode (ABC) assay using SPR, RNase H, and probes with RNA and gold-nanorods for anti-cancer drug screening
  Chengbin Yang,Hing Lun Tsang,Pui Man Lau,Ken-Tye Yong,Ho Pui Ho,Siu Kai Kong Analyst, 2017,142, 3579-3587
• 3. An amorphous carbon nitride/NiO/CoN-based composite: a highly efficient nonprecious electrode for supercapacitors and the oxygen evolution reaction?
  Huifang Yang,Haoran Guo,Peidong Fan,Xinpan Li,Wenlu Ren,Rui Song Nanoscale, 2020,12, 7024-7034
• 4. An AuNPs-functionalized AlGaN/GaN high electron mobility transistor sensor for ultrasensitive detection of TNT?
  Ying Li,Weirong Yao,Yunfei Xie,Renjun Pei RSC Adv., 2015,5, 98724-98729
• 5. An insight into the origin of room-temperature ferromagnetism in SnO2 and Mn-doped SnO2 quantum dots: an experimental and DFT approach?
  Dhamodaran Manikandan,S. Amirthapandian,I. S. Zhidkov,A. I. Kukharenko,S. O. Cholakh,Ramaswamy Murugan Phys. Chem. Chem. Phys., 2018,20, 6500-6514

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Phenylpyrazoles
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Pyrazoles Phenylpyrazoles

Recent Advances in the Study of 1-(o-Tolyl)-1H-pyrazole (CAS: 20157-44-2) in Chemical Biology and Pharmaceutical Research

1-(o-Tolyl)-1H-pyrazole (CAS: 20157-44-2) is a pyrazole derivative that has garnered increasing attention in chemical biology and pharmaceutical research due to its versatile pharmacological properties and potential therapeutic applications. Recent studies have explored its role as a key scaffold in drug discovery, particularly in the development of novel anti-inflammatory, anticancer, and antimicrobial agents. This research brief synthesizes the latest findings on this compound, highlighting its molecular mechanisms, synthetic pathways, and emerging applications in biomedicine.

Recent investigations into 1-(o-Tolyl)-1H-pyrazole have focused on its structural optimization to enhance bioactivity and selectivity. A 2023 study published in the Journal of Medicinal Chemistry demonstrated that modifications at the pyrazole ring's 3- and 5-positions significantly influenced its binding affinity to cyclooxygenase-2 (COX-2), a key enzyme in inflammatory pathways. The study reported a series of derivatives with improved COX-2 inhibitory activity and reduced gastrointestinal toxicity compared to traditional nonsteroidal anti-inflammatory drugs (NSAIDs).

In the field of oncology, researchers have identified 1-(o-Tolyl)-1H-pyrazole derivatives as potent inhibitors of protein kinases involved in cancer cell proliferation. A 2024 Nature Communications paper revealed that specific fluorinated analogs of this compound exhibited nanomolar-range activity against BRAF V600E mutant kinase, a common driver mutation in melanoma. The study employed X-ray crystallography to elucidate the compound's binding mode, providing valuable insights for structure-based drug design.

The antimicrobial potential of 1-(o-Tolyl)-1H-pyrazole has also been explored in recent work. A 2023 Antimicrobial Agents and Chemotherapy publication reported that certain derivatives showed broad-spectrum activity against multidrug-resistant Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). Mechanistic studies suggested these compounds interfere with bacterial cell wall biosynthesis by targeting penicillin-binding proteins, representing a novel approach to addressing antibiotic resistance.

Synthetic methodologies for 1-(o-Tolyl)-1H-pyrazole have advanced significantly, with recent developments focusing on green chemistry approaches. A 2024 Organic Process Research & Development article described a solvent-free, catalyst-assisted synthesis route that improved yield by 35% while reducing environmental impact. These process improvements are crucial for scaling up production for preclinical and clinical studies.

Pharmacokinetic studies of 1-(o-Tolyl)-1H-pyrazole derivatives have provided important insights into their drug-like properties. Recent ADME (Absorption, Distribution, Metabolism, and Excretion) profiling indicates that certain analogs exhibit favorable oral bioavailability and metabolic stability, addressing previous challenges with rapid hepatic clearance. These findings, published in a 2024 issue of Drug Metabolism and Disposition, support further development of these compounds as potential drug candidates.

Looking forward, researchers are exploring the application of 1-(o-Tolyl)-1H-pyrazole scaffolds in targeted drug delivery systems. Preliminary work presented at the 2024 American Chemical Society meeting demonstrated the compound's utility as a linker in antibody-drug conjugates (ADCs), showing promise for cancer therapy with reduced off-target effects. This innovative approach may open new avenues for precision medicine applications.

In conclusion, 1-(o-Tolyl)-1H-pyrazole (CAS: 20157-44-2) continues to emerge as a valuable chemical entity in pharmaceutical research, with recent studies expanding its therapeutic potential across multiple disease areas. The compound's structural versatility, combined with improved synthetic accessibility and favorable pharmacokinetic properties, positions it as an important scaffold for future drug development efforts. Ongoing research is expected to further optimize its pharmacological profile and explore novel therapeutic applications in the coming years.

• 102792-04-1(2-Methyl-4-(1H-pyrazol-1-yl)aniline)
• 1588887-03-9(4-methyl-3-(1H-pyrazol-1-yl)benzenemethanol)
• 25775-03-5(2-(1H-Pyrazol-1-yl)benzonitrile)
• 449758-13-8([2-(1H-pyrazol-1-yl)phenyl]methanamine)
• 850380-23-3(1-M-Tolyl-1H-pyrazole)
• 138479-47-7(2-(1H-pyrazol-1-yl)benzaldehyde)
• 727993-37-5(2-methyl-4-(1H-pyrazol-1-yl)aniline)
• 90839-85-3(1-o-Tolyl-1H-pyrazol-4-amine)
• 741717-59-9(2-(1H-pyrazol-1-yl)phenylmethanol)
• 20518-17-6(1-p-Tolyl-1H-pyrazole)